J Frontier Co.,Ltd.
Full-Year Financial Results for May 2026 Fiscal Year | Sales of ¥22.2 billion (YoY +3.4%)
In the full-year financial results for May 2026, the company achieved sales of ¥22.2 billion and operating profit of ¥312 million. Both figures increased YoY by 3.4% and with improved profit margins, signaling stable growth and prospects for future expansion.
Key Figures
- Sales: ¥22.2 billion (YoY +3.4%)
- Operating Profit: ¥312 million (YoY +6.0 times)
- Planned Sales: ¥26.5 billion (2027/5)
AI要約
Performance Overview
In the full-year period ending May 2026, J-Frontier Corporation achieved sales of ¥22.2 billion and operating profit of ¥312 million, representing a YoY increase of 3.4% in sales and a significant rise in operating profit. Profit margins also improved, indicating steady business growth. Expansion of medical infrastructure and online healthcare is expected to continue driving growth.
Future Outlook
For the fiscal year ending May 2027, the company plans to achieve sales of ¥26.5 billion and operating profit of ¥1 billion, with a particularly high growth forecast for operating income. Strengthening of the business foundation and expansion into new business fields aim to enhance profitability. The firm will promote healthcare digital transformation and collaboration with local governments to pursue long-term growth.
J-Frontier Corporation
Company overview · Stock price · Financial data · All IR
